At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 74 enrolled
Drug / intervention
furosemide +1 moredrug
Likely dose
furosemide 0.2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial
Bambino Gesù Hospital and Research Institute·interventional·Posted Jun 27, 2012·Updated Jul 24, 2014
In Brief
A Phase 3 clinical trial evaluating furosemide and ethacrynic acid for Fluid Overload. Completed, enrolled 74 participants across 1 site.
Detailed Summary
This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFluid Overload
CountriesItaly
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 2012
Enrollment StartOct 2012
Primary CompletionJul 2013
Study CompletionNov 2013
TodayJul 2026
First PostedJun 27, 2012
Enrollment StartOct 1, 2012
Primary CompletionJul 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.0 years ago
Interventions
furosemidedrug
furosemide, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours
ethacrynic aciddrug
ethacrynic acid, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours